Kag, I think I have an answer. Previously I was hearing thoughts of a buyout. I think the odds are extremely high that Inverness is not giving any competitors any reason to look at BioCurex, so they can add us to their aggressive list of acquisitions.
Look at this mindblowing shopping spree by Inverness in the last 12 months alone:
14 acquisitions:
Medox Chemicals
Promeson
First Check Diagnostics
Benelux Distributors Orange Medical
Biosite
Cholestech
Panbrio Limited
Alere Medical
Paridigm Health
BBI Holdings
Matritech
Redwood Toxicology Lab
Let's all get real. I had no idea how aggressive they were. Every deal they ever made is published on their website.....EXCEPT.....you guessed it.......Biocurex. I am probably buying more of our stock, because it appears there is a definite pattern. Inverness will want the whole pie and not just a piece. I hope Dr Moro divides the company as he said he would 4 years ago, he sells off the diagnostics and he buys Combupharma and takes over on the therapy side to speed up the treatment of cancer.
I think that Inverness is so heavily followed it would cost them big bucks if they let on to them doing a deal with BioCurex.
This was probably a bigger deal than any of us realized. I am glad I held on and IMO I expect we will be bought shortly. I didn't see it till I just went to their website and looked for a press release on us and didn't see one, but I have never seen a company this agressive to buy 14 companies in ONE year. The question is will Dr Moro let it happen?
